Spironolactone and Monocyte count increased - a phase IV clinical study of FDA data

Summary:

Monocyte count increased is reported as a side effect among people who take Spironolactone (spironolactone), especially for people who are male, 60+ old, also take Lasix, and have Cardiac failure.

The phase IV clinical study analyzes which people have Monocyte count increased when taking Spironolactone. It is created by eHealthMe based on reports of 119,147 people who have side effects when taking Spironolactone from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Monocyte count increased?

Monocyte count increased is found to be associated with 602 drugs and 690 conditions by eHealthMe. Check the latest studies of Monocyte count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

119,147 people reported to have side effects when taking Spironolactone.
Among them, 25 people (0.02%) have Monocyte count increased.

Could Spironolactone cause Monocyte count increased?

Among these 25 people:

What is the gender of people who have Monocyte count increased when taking Spironolactone? *

female: 50 %
male: 50 %

What is the age of people who have Monocyte count increased when taking Spironolactone? *

What are other drugs people take besides Spironolactone? *

What are other side effects people have besides Monocyte count increased? *

Blood Urea Increased: 11 people, 44.00%
Haemoglobin Decreased: 11 people, 44.00%
Red Blood Cell Count Decreased: 10 people, 40.00%
Lymphocyte Count Decreased: 10 people, 40.00%
Blood Glucose Increased: 10 people, 40.00%
Haematocrit Decreased: 10 people, 40.00%
White Blood Cell Count Increased: 8 people, 32.00%
Blood Creatinine Increased: 8 people, 32.00%
Blood Albumin Decreased: 7 people, 28.00%
Thrombocytopenia (decrease of platelets in blood): 7 people, 28.00%

What are the existing conditions these people have? *

Cardiac Failure: 3 people, 12.00%
Affective Disorder (mental disorder): 2 people, 8.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.00%
High Blood Cholesterol: 2 people, 8.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 4.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 4.00%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 1 person, 4.00%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 4.00%
Headache (pain in head): 1 person, 4.00%
Gout (uric acid crystals building up in the body): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and have Monocyte count increased?

- Check whether Monocyte count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spironolactone:

Spironolactone (122,947 reports)

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Monocyte count increased:

Monocyte count increased (602 drugs)

Browse all the conditions that are associated with Monocyte count increased:

Monocyte count increased (690 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Spironolactone) and Spironolactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.